Compugen Ltd. cash flow to debt ratio of 1.07K% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.

Compugen Ltd.'s free cash flow has decreased 36.69% from $49.49M last year to $31.33M, signaling decreasing performance

Compugen Ltd.'s debt to equity ratio is 0.03, which means that the company's assets are healthy financed, signaling financial stability.

Compugen Ltd.'s debt has decreased relative to shareholder equity from 0.05 last year to 0.03 today, signaling strengthened financials

Compugen Ltd. has a net cash position, so leverage is healthy.

Compugen Ltd. earns at least as much interest as it pays. Interest obligations are fully covered.

Compugen Ltd.'s profit margin has increased (-193.11%) in the last year from -51.07% to 47.55%, signaling increasing performance

Compugen Ltd.'s short-term assets of $148.02M exceed its short-term liabilities of $22.57M

Compugen Ltd.'s return on assets of 25.43% is higher than the 5.00% threshold, indicating efficient asset utilization

Compugen Ltd.'s return on equity of 42.57%, is higher than 15.00%, indicating good performance

Compugen Ltd.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Compugen Ltd. had positive net income in only 1 out of 5 years, indicating unstable earnings

Compugen Ltd. has positive free cash flow, indicating the company generates cash after capital expenditures

Compugen Ltd. has a free cash flow yield of 14.16%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Compugen Ltd.'s yearly earnings has increased -348.35% since last year from $-14.23M to $35.34M, signaling increasing performance

Compugen Ltd.'s yearly revenue has increased 161.14% since last year from $27.86M to $72.76M, signaling increasing performance

ROIC 26.00% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.

Compugen Ltd.'s 3-year revenue CAGR of 113.28% is positive, indicating growing revenue over the past 3 years

Compugen Ltd. had revenue growth in 4 out of 5 years, indicating consistent revenue performance

Compugen Ltd. had positive ROE in only 1 out of 5 years, indicating inconsistent returns on equity

Compugen Ltd. has insufficient data to evaluate this check.

Compugen Ltd. has an earnings yield of 15.89%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings

Compugen Ltd. is undervalued relative to its fair value price of 3.29 based on EBITDA multiple model

Compugen Ltd. has an EV/EBITDA ratio of 2.19x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

Compugen Ltd. is overvalued relative to its fair value price of -8.02 based on Earnings Fair Value model

Compugen Ltd. had non-positive diluted EPS five years ago; the PEG ratio is not meaningful and the check fails.

Compugen Ltd. has a price-to-book ratio of 2.50x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Compugen Ltd. has a price-to-sales ratio of 2.99x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue